Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7489

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907489)

Rosuvastatin Calcium 5 mg film-coated tablets by A-S Medication Solutions. The label shows that each tablet contains Rosuvastatin calcium USP equivalent to Rosuvastatin 5 mg. The package contains 90 tablets and storage instructions specify 68 to 77 degrees Fahrenheit. The product is for oral use, labeled with NDC 50090-7489.*

FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

A cumulative incidence graph displaying the percentage over a 5-year period comparing Rosuvastatin Calcium (solid line) and placebo (dashed line). The chart includes hazard ratio and confidence interval statistics, with a table below indicating the number of subjects at risk for each group over time.*

FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

A data table comparing clinical event outcomes for Rosuvastatin Calcium 20 mg versus placebo 20 mg, showing the number of events, event rates per 1000 patient-years, hazard ratios with 95% confidence intervals, and p-values for endpoints including major cardiovascular events, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. A hazard ratio forest plot is shown on the right.*

FDA Label Image

Figure 3. (Rosuvastatin Fig3)

A box-and-whisker plot comparing the percent change from baseline in LDL-C for four statins (Rosuvastatin, Atorvastatin, Simvastatin, Pravastatin) at various doses in mg. The x-axis shows dose ranges per drug, and the y-axis shows percent change in LDL-C, with values from 0 to -75%. Each drug's effect on LDL-C reduction is visualized at doses including 10, 20, and 40 mg, with some drugs showing data up to 80 mg.*

FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical structure diagram of Rosuvastatin Calcium showing its molecular arrangement including functional groups and calcium ion coordination.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.